Medifast Inc
MEDNYSECIK 910329Consumer staplesFiscal year ends Dec 31
Reports and events: 323 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2608:50 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001628280-26-067165 |
| 2026-10-2608:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-067151 |
| 2026-08-2116:01 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-26-092590 |
| 2026-08-0316:50 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-051928 |
| 2026-08-0316:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-051845 |
| 2026-07-1708:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-048574 |
| 2026-06-0108:59 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-039293 |
| 2026-05-2616:26 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-038109 |
| 2026-05-0416:51 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-029898 |
| 2026-05-0416:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-029812 |
| 2026-04-0616:06 ET | DEF 14A | Proxy statementPeriod 2026-05-19 | 0001628280-26-023890 |
| 2026-03-2012:55 ET | SCHEDULE 13D | Ownership report, active investor | 0001213900-26-032212 |
| 2026-03-2008:35 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-019983 |
| 2026-02-1716:54 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-008656 |
| 2026-02-1716:44 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-008641 |
| 2026-01-0509:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-000235 |
| 2025-11-0316:51 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-048332 |
| 2025-11-0316:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-048251 |
| 2025-08-0416:51 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000910329-25-000016 |
| 2025-08-0416:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000910329-25-000015 |
| 2025-06-2016:59 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-25-032457 |
| 2025-04-2916:10 ET | DEF 14A | Proxy statementPeriod 2025-06-18 | 0001628280-25-020673 |
| 2025-04-2816:50 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-020341 |
| 2025-04-2816:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-020336 |
| 2025-02-1816:50 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-006094 |
| 2025-02-1816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-006036 |
| 2024-11-0416:50 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-045040 |
| 2024-11-0416:20 ET | 8-K | 1.02 Termination of a material agreement; 2.02 Results of operations | 0001628280-24-045012 |
| 2024-08-0516:50 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-034791 |
| 2024-08-0516:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-034743 |
| 2024-06-2117:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-24-029369 |
| 2024-04-2916:51 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-019046 |
| 2024-04-2916:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-019030 |
| 2024-04-2617:17 ET | DEF 14A | Proxy statementPeriod 2024-06-19 | 0001628280-24-018731 |
| 2024-02-2017:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-005673 |
| 2024-02-2016:50 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-005620 |
| 2023-12-1307:42 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-041392 |
| 2023-11-0616:50 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001628280-23-037080 |
| 2023-11-0616:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-037043 |
| 2023-09-2708:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-033071 |
| 2023-09-0716:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-031708 |
| 2023-08-0717:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-027839 |
| 2023-08-0716:50 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001628280-23-027815 |
| 2023-06-1516:17 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-022233 |
| 2023-06-0117:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-020530 |
| 2023-05-0116:47 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001628280-23-014622 |
| 2023-05-0116:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-014561 |
| 2023-05-0108:39 ET | DEF 14A | Proxy statement | 0001628280-23-014346 |
| 2023-04-2017:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-23-012300 |
| 2023-03-1616:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-008303 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 31, 2026, 14:35 ET. Listed shows no prices and gives no investment advice.